# Linagliptin and Mesenchymal Stem Cells: A Pilot Study

> **NCT02442817** · PHASE4 · COMPLETED · sponsor: **University of Nevada, Reno** · enrollment: 10 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Linagliptin

## Key facts

- **NCT ID:** NCT02442817
- **Lead sponsor:** University of Nevada, Reno
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-02
- **Primary completion:** 2018-03-02
- **Final completion:** 2018-03-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02442817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02442817, "Linagliptin and Mesenchymal Stem Cells: A Pilot Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02442817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*